Business Context and Reporting Period
This Form 8-K Current Report from Exicure, Inc. (Nasdaq: XCUR) covers events occurring on December 29, 2020, with the report filed on January 5, 2021. The filing primarily addresses changes to the Company's Board of Directors and Audit Committee.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance changes and director compensation arrangements.
Material Changes
- Resignation: Jay R. Venkatesan, M.D., resigned from the Board of Directors and the Audit Committee effective December 29, 2020. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Appointment: James Sulat was appointed as a director and Chairperson of the Audit Committee, effective January 2, 2021. His term expires at the 2023 annual meeting of stockholders.
Guidance, Outlook, and Compensation
The filing details the compensatory arrangement for the newly appointed director, James Sulat:
- Cash Compensation: $35,000 per fiscal year for Board service and $15,000 per year for serving as Audit Committee Chairperson.
- Equity Grant: An initial option grant of 43,386 shares of common stock with an exercise price of $1.82 (closing price on January 4, 2021).
- Vesting: Options vest in equal monthly installments over a three-year period, contingent on continued service.
- Outlook: No financial guidance or operational outlook is provided in this filing.
Investor Verification Checklist
- Verify the effective dates of Dr. Venkatesan's resignation and Mr. Sulat's appointment to ensure accurate governance records.
- Review the Company's definitive proxy statement (Schedule 14A filed April 21, 2020) to confirm the standard compensation program details referenced for Mr. Sulat.
- Confirm the vesting schedule and exercise price of the 43,386 stock options granted to Mr. Sulat.
- Check for any subsequent filings regarding the composition of the Audit Committee to ensure compliance with Nasdaq listing standards.